Effectiveness and Efficiency of Assertive Outreach for Schizophrenia in Germany: study protocol on a pragmatic quasi-experimental controlled trial

Anke Bramesfeld; Jörn Moock; Kirsten Kopke; Dorothea Büchtemann; Denise Kästner; Jeanett Radisch; Wulf Rössler

doi:10.1186/1471-244X-13-56

Effectiveness and Efficiency of Assertive Outreach for Schizophrenia in Germany: study protocol on a pragmatic quasi-experimental controlled trial

Anke Bramesfeld
, Jörn Moock
, Kirsten Kopke
, Dorothea Büchtemann
, Denise Kästner
, Jeanett Radisch
, Wulf Rössler

Research output: Journal contributions › Journal articles › Research › peer-review

9 Citations (Scopus)

Abstract

Background: A model of assertive outreach (AO) in which office-based psychiatrists collaborate with ambulatory nursing services for providing intensive home-treatment is currently being implemented in rural areas of Lower Saxony, Germany. The costs of the model are reimbursed by some of the statutory health insurance companies active in Lower Saxony. Effectiveness and efficiency of this model for patients suffering from schizophrenia is evaluated in a pragmatic and prospective trial. Methods: Quasi-experimental controlled trial: patients receiving the intervention are all those receiving AO; controls are patients not eligible for AO based on their health insurance affiliation. Eligibility criteria: clinical diagnosis of schizophrenia (ICD-10 F.20), aged at least 18 years and being moderately to severely impaired in global functioning. Primary outcome: admission and days spent in psychiatric inpatient care; secondary outcomes: clinical and functional status; patient satisfaction with chronic care; health care costs. Follow-up time: 6 and 12 months. Discussion: The study faces many challenges typical to pragmatic trials such as the rejection of randomisation by service providers, the quality of treatment as usual (TAU) to which the intervention will be compared, and the impairment of the study subjects. Solutions of how to deal with these challenges are presented and discussed in detail. Trial registration: International Standard Randomised Controlled Trial Number: http://ISRCTN34900108, German Clinical Trial Register: http://DRKS00003351.

Original language	English
Article number	56
Journal	BMC Psychiatry
Volume	13
Number of pages	14
DOIs	https://doi.org/10.1186/1471-244X-13-56
Publication status	Published - 15.02.2013

Bibliographical note

Funding Information:
The study is part of the project “Basic Principles and Evaluation of Integrated Care for Mentally Ill Persons”. It is funded by a 2.3 million Euro grant (CCI NO 2007DE161PR001) from the Innovation-Incubator at Leuphana University Luneburg. The Innovation-Incubator is a large scale project at Leuphana University that aims for economic development through research in rural regions in North Lower Saxony. The Innovation-Incubator is funded by European Funds for Regional Development and by the Federal State of Lower Saxony. We are grateful to the colleagues at IVPNetworks GmbH who manage the intervention described in the study protocol, for supporting this study; also many thanks to Sharon Janicki for revising the language of the article.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research areas and keywords

Health sciences
Controlled trial
Home treatment
Integrated care
Psychiatry
Seriously mentally ill

ASJC Scopus Subject Areas

Psychiatry and Mental health

Access to Document

10.1186/1471-244X-13-56Licence: CC BY

VolltextFinal published version, 220 KBLicence: CC BY

TM 1.1 KT 01 - Vernetzte Versorgung: Vernetzte Versorgung - Grundlagen und Evaluierung der Versorgung psychisch erkrankter Menschen
Rössler, W. (Project manager, academic), Kawohl, W. (Project manager, academic), Moock, J. (Project staff) & Heuchert, S. (Coordination)
Investitions- und Förderbank Niedersachsen – NBank
01.09.10 → 31.03.16
Project: Research

Cite this

@article{51d6f191fa4e490ca630bae9f0c218c3,

title = "Effectiveness and Efficiency of Assertive Outreach for Schizophrenia in Germany: study protocol on a pragmatic quasi-experimental controlled trial",

abstract = "Background: A model of assertive outreach (AO) in which office-based psychiatrists collaborate with ambulatory nursing services for providing intensive home-treatment is currently being implemented in rural areas of Lower Saxony, Germany. The costs of the model are reimbursed by some of the statutory health insurance companies active in Lower Saxony. Effectiveness and efficiency of this model for patients suffering from schizophrenia is evaluated in a pragmatic and prospective trial. Methods: Quasi-experimental controlled trial: patients receiving the intervention are all those receiving AO; controls are patients not eligible for AO based on their health insurance affiliation. Eligibility criteria: clinical diagnosis of schizophrenia (ICD-10 F.20), aged at least 18 years and being moderately to severely impaired in global functioning. Primary outcome: admission and days spent in psychiatric inpatient care; secondary outcomes: clinical and functional status; patient satisfaction with chronic care; health care costs. Follow-up time: 6 and 12 months. Discussion: The study faces many challenges typical to pragmatic trials such as the rejection of randomisation by service providers, the quality of treatment as usual (TAU) to which the intervention will be compared, and the impairment of the study subjects. Solutions of how to deal with these challenges are presented and discussed in detail. Trial registration: International Standard Randomised Controlled Trial Number: http://ISRCTN34900108, German Clinical Trial Register: http://DRKS00003351.",

keywords = "Health sciences, Controlled trial, Home treatment, Integrated care, Psychiatry, Seriously mentally ill",

author = "Anke Bramesfeld and J{\"o}rn Moock and Kirsten Kopke and Dorothea B{\"u}chtemann and Denise K{\"a}stner and Jeanett Radisch and Wulf R{\"o}ssler",

note = "Funding Information: The study is part of the project “Basic Principles and Evaluation of Integrated Care for Mentally Ill Persons”. It is funded by a 2.3 million Euro grant (CCI NO 2007DE161PR001) from the Innovation-Incubator at Leuphana University Luneburg. The Innovation-Incubator is a large scale project at Leuphana University that aims for economic development through research in rural regions in North Lower Saxony. The Innovation-Incubator is funded by European Funds for Regional Development and by the Federal State of Lower Saxony. We are grateful to the colleagues at IVPNetworks GmbH who manage the intervention described in the study protocol, for supporting this study; also many thanks to Sharon Janicki for revising the language of the article.",

year = "2013",

month = feb,

day = "15",

doi = "10.1186/1471-244X-13-56",

language = "English",

volume = "13",

journal = "BMC Psychiatry",

issn = "1471-244X",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Effectiveness and Efficiency of Assertive Outreach for Schizophrenia in Germany

T2 - study protocol on a pragmatic quasi-experimental controlled trial

AU - Bramesfeld, Anke

AU - Moock, Jörn

AU - Kopke, Kirsten

AU - Büchtemann, Dorothea

AU - Kästner, Denise

AU - Radisch, Jeanett

AU - Rössler, Wulf

N1 - Funding Information: The study is part of the project “Basic Principles and Evaluation of Integrated Care for Mentally Ill Persons”. It is funded by a 2.3 million Euro grant (CCI NO 2007DE161PR001) from the Innovation-Incubator at Leuphana University Luneburg. The Innovation-Incubator is a large scale project at Leuphana University that aims for economic development through research in rural regions in North Lower Saxony. The Innovation-Incubator is funded by European Funds for Regional Development and by the Federal State of Lower Saxony. We are grateful to the colleagues at IVPNetworks GmbH who manage the intervention described in the study protocol, for supporting this study; also many thanks to Sharon Janicki for revising the language of the article.

PY - 2013/2/15

Y1 - 2013/2/15

N2 - Background: A model of assertive outreach (AO) in which office-based psychiatrists collaborate with ambulatory nursing services for providing intensive home-treatment is currently being implemented in rural areas of Lower Saxony, Germany. The costs of the model are reimbursed by some of the statutory health insurance companies active in Lower Saxony. Effectiveness and efficiency of this model for patients suffering from schizophrenia is evaluated in a pragmatic and prospective trial. Methods: Quasi-experimental controlled trial: patients receiving the intervention are all those receiving AO; controls are patients not eligible for AO based on their health insurance affiliation. Eligibility criteria: clinical diagnosis of schizophrenia (ICD-10 F.20), aged at least 18 years and being moderately to severely impaired in global functioning. Primary outcome: admission and days spent in psychiatric inpatient care; secondary outcomes: clinical and functional status; patient satisfaction with chronic care; health care costs. Follow-up time: 6 and 12 months. Discussion: The study faces many challenges typical to pragmatic trials such as the rejection of randomisation by service providers, the quality of treatment as usual (TAU) to which the intervention will be compared, and the impairment of the study subjects. Solutions of how to deal with these challenges are presented and discussed in detail. Trial registration: International Standard Randomised Controlled Trial Number: http://ISRCTN34900108, German Clinical Trial Register: http://DRKS00003351.

AB - Background: A model of assertive outreach (AO) in which office-based psychiatrists collaborate with ambulatory nursing services for providing intensive home-treatment is currently being implemented in rural areas of Lower Saxony, Germany. The costs of the model are reimbursed by some of the statutory health insurance companies active in Lower Saxony. Effectiveness and efficiency of this model for patients suffering from schizophrenia is evaluated in a pragmatic and prospective trial. Methods: Quasi-experimental controlled trial: patients receiving the intervention are all those receiving AO; controls are patients not eligible for AO based on their health insurance affiliation. Eligibility criteria: clinical diagnosis of schizophrenia (ICD-10 F.20), aged at least 18 years and being moderately to severely impaired in global functioning. Primary outcome: admission and days spent in psychiatric inpatient care; secondary outcomes: clinical and functional status; patient satisfaction with chronic care; health care costs. Follow-up time: 6 and 12 months. Discussion: The study faces many challenges typical to pragmatic trials such as the rejection of randomisation by service providers, the quality of treatment as usual (TAU) to which the intervention will be compared, and the impairment of the study subjects. Solutions of how to deal with these challenges are presented and discussed in detail. Trial registration: International Standard Randomised Controlled Trial Number: http://ISRCTN34900108, German Clinical Trial Register: http://DRKS00003351.

KW - Health sciences

KW - Controlled trial

KW - Home treatment

KW - Integrated care

KW - Psychiatry

KW - Seriously mentally ill

UR - https://www.scopus.com/pages/publications/84873743723

UR - https://www.mendeley.com/catalogue/a0c64186-165f-34b0-bf46-ba0263f25ee4/

U2 - 10.1186/1471-244X-13-56

DO - 10.1186/1471-244X-13-56

M3 - Journal articles

C2 - 23414234

SN - 1471-244X

VL - 13

JO - BMC Psychiatry

JF - BMC Psychiatry

M1 - 56

ER -

Effectiveness and Efficiency of Assertive Outreach for Schizophrenia in Germany: study protocol on a pragmatic quasi-experimental controlled trial

Abstract

Bibliographical note

UN SDGs

Research areas and keywords

ASJC Scopus Subject Areas

Access to Document

Fingerprint

Projects

TM 1.1 KT 01 - Vernetzte Versorgung: Vernetzte Versorgung - Grundlagen und Evaluierung der Versorgung psychisch erkrankter Menschen

Cite this